Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
نویسنده
چکیده
Abbreviations: ACE 5 ASA and Carotid Endarterectomy; BI 5 Barthel Index; CAPRIE 5 Clopidogrel vs Aspirin in Patients at Risk of Ischemic Events; CAST 5 Chinese Acute Stroke Trial; CI 5 confidence interval; CVST 5 cerebral venous sinus thrombosis; DVT 5 deep venous thrombosis; ECASS 5 European Cooperative Acute Stroke Study; ESPS 5 European Stroke Prevention Study; FDA 5 Food and Drug Administration; GOS 5 Glasgow Outcome Scale; ICH 5 intracerebral hematoma; INR 5 international normalized ratio; IST 5 International Stroke Trial; MAST 5 Multicentre Acute Stroke Trial; MCA 5 middle cerebral artery; MI 5 myocardial infarction; mRS 5 modified Rankin Scale; NIHSS 5 National Institutes of Health Stroke Scale; NINDS 5 National Institute of Neurological Disorders and Stroke; OR 5 odds ratio; PE 5 pulmonary embolism; PFO 5 patent foramen ovale; rpro-UK 5 recombinant pro-urokinase; TASS 5 Ticlopidine Aspirin Stroke Study; TIA 5 transient ischemic attack; TOAST 5 Trial of ORG 10172 in Acute Stroke Treatment; tPA 5 tissue plasminogen activator; TTP 5 thrombotic thrombocytopenic purpura (CHEST 2001; 119:300S–320S)
منابع مشابه
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
Background: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. The aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous th...
متن کاملRisks and Benefits of Early Antithrombotic Therapy after Thrombolytic Treatment in Patients with Acute Stroke
BACKGROUND Current guidelines recommend withholding antithrombotic therapy (ATT) for at least 24 h in patients with acute ischemic stroke treated with thrombolytic therapy. Herein, we report a retrospective analysis of a single-centre experience on the safety and efficacy of antithrombotic therapy (ATT) started before or after 24 h of intravenous thrombolysis in a cohort of acute ischemic strok...
متن کاملA clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors
Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...
متن کاملAntithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
OBJECTIVES This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). METHODS We generated treatment recommendations (Grade 1) and suggestions (Grade 2) based on high (A), moderate (B), and low (C) quality evidence. RESULTS In patients with acute ischemic stroke, we recommend IV recombinant tissue plasminogen activa...
متن کاملXIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.
A revival of interest in antithrombotic agents for the treatment of ischemic cerebrovascular disease has resulted in the widespread use of oral anticoagulants for the prophylaxis and therapy of the ischemic variety of stroke, and has generated enthusiasm for the use of platelet-suppressant agents such as aspirin, dipyridamole, and sulfinpyrazone. In delineating the several clinical types of foc...
متن کاملFactors Affecting the Length of Hospital Stay in Patients with Ischemic Stroke Treated by Intravenous Thrombolysis
Background and purpose: Ischemic stroke is one of the most common neurological diseases that leads to disability in many cases. The aim of this study was to investigate the factors affecting the duration of hospitalization in patients with ischemic stroke undergoing thrombolytic therapy. Materials and methods: This retrospective descriptive-analytical study was performed in consecutive adult p...
متن کامل